AOTI, INC. (AIM: AOTI), a medical technology group specialising in durable wound healing and amputation prevention, reported on Monday that the Centers for Medicare and Medicaid Services (CMS) will hold a public Contractor Advisory Committee (CAC) meeting on 11 December 2024. The meeting, facilitated by Durable Medical Equipment Medicare Administrative Contractors (DME MACs), will review potential revisions to the Oxygen and Oxygen Equipment Local Coverage Determination (LCD) to include Topical Oxygen Therapy for wound healing.

The CAC will assess clinical evidence and discuss its relevance to the requested LCD changes, informing CMS's decision-making process. Following the CAC, DME MACs are expected to publish a proposed LCD and have up to 365 days to finalise it.

Founded in 2006, AOTI offers innovative non-invasive therapies like TWO2 to treat chronic wounds and reduce hospitalisations and amputations, supported by robust RCT and real-world data. Regulatory clearances include FDA, CE Mark, MHRA and multiple other national agencies.